@article{ca3752472f9e4312bbfe0fa8b6c4705c,
title = "Is there a role for clozapine in the treatment of children and adolescents?",
author = "Findling, {Robert L.} and Frazier, {Jean A.} and Ginny Gerbino-Rosen and Kranzler, {Harvey N.} and Sanjiv Kumra and Kratochvil, {Christopher J.}",
note = "Funding Information: Disclosure: None of the authors have conducted industry-funded studies of clozapine. Drs. Kumra, Kranzler, and Gerbino-Rosen have conducted studies of clozapine funded by the National Institute of Mental Health, but with study drug donated by Novartis. Dr. Kratochvil was previously a speaker for Novartis and has received grant support from, is a consultant to, and/or member of the speakers' bureaus of Eli Lilly, GlaxoSmithKline, Forest, Shire, Cephalon, Novartis, McNeil, Organon, AstraZeneca, and Pfizer. Dr. Findling has been a consultant to and conducted studies for Novartis, the manufacturer of Clozaril, and receives or has received research support from, acted as a consultant to, and/or served on the speakers' bureaus of Abbott, AstraZeneca, Bristol-Myers Squibb, Celltech-Medeva, Forest, GlaxoSmithKline, Johnson & Johnson, Lilly, New River, Novartis, Otsuka, Pfizer, Sanofi-Aventis, Shire, Solvay, and Wyeth. Dr. Frazier has received research support from, acted as a consultant to, and/or served on the speakers' bureaus of AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Forest Research Institute, Johnson & Johnson Pharmaceutical Research and Development, Otsuka Pharmaceutical Inc., and Pfizer. The other authors have no financial relationships to disclose. ",
year = "2007",
month = mar,
doi = "10.1097/chi.0b013e3180ed94e",
language = "English (US)",
volume = "46",
pages = "423--428",
journal = "Journal of the American Academy of Child and Adolescent Psychiatry",
issn = "0890-8567",
publisher = "Elsevier Inc.",
number = "3",
}